Trial of a Secondary Stroke Prevention Program
NCT01071408 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54
Last updated 2012-05-16
Summary
The purpose of this study is to determine whether an outpatient program can reduce the risk of recurrent stroke.
Conditions
- Ischemic Stroke
- Transient Ischemic Attack
Interventions
- OTHER
-
Stroke prevention care program
Stroke prevention care program consists of group clinics, telephone coordination of care, and tracking of care through registries in the first 7 months after stroke or TIA presentation. A nurse practitioner will follow algorithms to adjust medications and to motivate patients to improve lifestyle habits.
Sponsors & Collaborators
-
National Institute of Neurological Disorders and Stroke (NINDS)
collaborator NIH -
Sepulveda Research Corporation
lead INDUSTRY
Principal Investigators
-
Eric M Cheng, MD, MS · VA Long Beach Healthcare System
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-03-31
- Primary Completion
- 2012-05-31
- Completion
- 2012-05-31
Countries
- United States
Study Locations
More Related Trials
-
Secondary Prevention of Stroke Through Non-drug Therapeutic Weight Reduction
NCT01721538 ·Status: UNKNOWN ·Phase: NA
-
Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
NCT01976936 ·Status: COMPLETED ·Phase: PHASE2
-
Intensified Secondary Prevention Intending a Reduction of Recurrent Events in TIA and Minor Stroke Patients
NCT01586702 ·Status: COMPLETED ·Phase: NA
-
IMPROVE Stroke Care- Developing and Optimizing Regional Systems of Stroke Care
NCT04242784 ·Status: COMPLETED
-
A Study of Survival and Outcome After Stroke
NCT01193569 ·Status: COMPLETED
-
Biomarkers of Acute Stroke in Clinic
NCT03897478 ·Status: UNKNOWN
-
A Clinical Trial to Assess the Acute Safety and Functional Outcome and Recovery After STROKE: The FIRST Trial
NCT01092819 ·Status: COMPLETED
-
The Effects of Disease Management Programs for Prevention of Recurrent Ischemic Stroke
NCT02121327 ·Status: COMPLETED ·Phase: NA
-
Short Message Service (SMS) Reminders for Stroke Secondary Preventative Medications
NCT02336412 ·Status: COMPLETED ·Phase: NA
-
REcurrent Stroke Prevention Through Personalized Education by Clinical Trainers (RESPPECT Trial)
NCT03861494 ·Status: COMPLETED ·Phase: NA
-
TNK-tPA Evaluation for Minor Ischemic Stroke With Proven Occlusion
NCT01654445 ·Status: COMPLETED ·Phase: PHASE2
-
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
NCT02549846 ·Status: COMPLETED ·Phase: PHASE4
-
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
NCT05691244 ·Status: RECRUITING ·Phase: PHASE3
-
Safety and Efficacy of Evolocumab in Ischemic Stroke
NCT05697185 ·Status: UNKNOWN ·Phase: PHASE4
-
Standard Medical Management in Secondary Prevention of Ischemic Stroke in China
NCT00664846 ·Status: COMPLETED ·Phase: NA
-
Intravenous Thrombosis and Patients with Prior Ischemic Stroke Within 3 Months
NCT06841978 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
E-Selectin Nasal Instillation to Prevent Secondary Stroke
NCT00069069 ·Status: WITHDRAWN ·Phase: PHASE1
-
To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection
NCT00238667 ·Status: COMPLETED ·Phase: PHASE3
-
Stroke Treatment With Acute Reperfusion and Simvastatin
NCT01073007 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset
NCT07094763 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Tenecteplase in ReperfUsion Therapy for Posterior Circulation Stroke With Extended Time Window: the TRUST Trial
NCT07073469 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Non-immunogenic Staphylokinase in Reperfusion Therapy of Ischemic Stroke in Routine Clinical Practice
NCT05697575 ·Status: RECRUITING
-
Neuroprotection in Acute Ischemic Stroke
NCT03320018 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy Study in Acute Ischaemic Stroke
NCT00144014 ·Status: COMPLETED ·Phase: PHASE2
-
Endovascular Therapy for Acute Ischemic Stroke Trial
NCT02350283 ·Status: COMPLETED ·Phase: PHASE3